Immune Response Following COVID-19 Vaccination

Status unconfirmed

Conditions studied: IgM and IgG in Blood

In brief

Few trials have reported the safety and efficacy of the COVID-19 vaccines. However, these trials were mostly focused on post-vaccination adverse events and short-term antibody detection with none monitoring the presence of immunoglobulin G (IgG) in blood at long-term follow-up after the vaccination. This study aims to evaluate the immune response in post-vaccinated individuals across a follow-up period of one year.

Key facts

Study ID

NCT04736524

Run by

Texas Cardiac Arrhythmia Research Foundation

People needed

500

Starts

2021-01-15

Expected to finish

2022-03-01

Last updated by the study team

2021-02-03

Who can join

Age: 16 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals that have received first dose of COVID-19 vaccine

You may not qualify if…

• Unwilling to provide informed consent
• Unwilling for the follow-up serological test during the 1-year enrollment

Where it is running

• Texas Cardiac arrhythmia Institute, St. David's Hospital — Austin, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.